Warfarin for Stroke Prevention Still Underused in Atrial Fibrillation | Zendy

Natan Cohen | Zendy; Dorit AlmozninoSarafian | Zendy; Irena Alon | Zendy; Oleg Gorelik | Zendy; Margarita Koopfer | Zendy; Shulamit Chachashvily | Zendy; Miriam Shteinshnaider | Zendy; Vladimir Litvinjuk | Zendy; David Modai | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Warfarin for Stroke Prevention Still Underused in Atrial Fibrillation

Author(s) -

Natan Cohen,

Dorit AlmozninoSarafian,

Irena Alon,

Oleg Gorelik,

Margarita Koopfer,

Shulamit Chachashvily,

Miriam Shteinshnaider,

Vladimir Litvinjuk,

David Modai

Publication year - 2000

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.31.6.1217

Subject(s) - medicine , warfarin , atrial fibrillation , aspirin , stroke (engine) , population , cardiology , surgery , mechanical engineering , environmental health , engineering

The value of warfarin in preventing stroke in patients with chronic atrial fibrillation is well established. However, the prevalence of such treatment generally lags behind actual requirements. The aim of this study was to evaluate doctor- and/or patient-related demographic, clinical, and echocardiographic factors that influence decision for warfarin treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research